GSK settles vast majority of Zantac claims for $2.2 billion
The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer
Delta Air Lines’ stock was headed for another post-earnings selloff on Thursday, after the air carrier missed third-quarter profit expectations...
Pfizer Inc.’s stock dipped early Thursday, after two of its former executives said they would not support an effort by...
COLA helps the roughly 67 million Social Security beneficiaries keep up with inflationary pressures
Impact of Hurricane Helene seen as claims rise 33,000 to 258,000
Tilray’s stock gained Thursday, after the cannabis and beverage company reported a smaller loss than expected for its fiscal first...
Investors who kept their money in the S&P since 1950, regardless of who was in power, would have made 10...
Average Rating